Leukemia researchHumansGraft vs Host DiseaseMaleFemaleMiddle Aged
Differential impact of graft-versus-host disease on post-transplant outcomes of chronic myelomonocytic leukemia according to transplant procedures.
Hidehiro Itonaga, Yasushi Miyazaki, Machiko Fujioka, Shuhei Kurosawa, Yasunobu Nagata, Yutaka Shimazu, Tomoaki Ueda, Naoyuki Uchida, Noriko Doki, Tetsuya Nishida, Noboru Asada, Masatsugu Tanaka, Satoru Takada, Masatoshi Sakurai, Mineo Kurokawa
Published: 202510.1016/j.leukres.2025.108134
Abstract
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) provides curative outcomes for chronic myelomonocytic leukemia (CMML). We conducted a retrospective study to clarify the protective impact of acute and chronic graft-versus-host disease (…
Preview only. Read the full abstract at the source